Umbrella Genomicsec Company S.A.S. Company Profile - Ecuador | Financials & Key Executives

Umbrella Genomicsec Company S.A.S. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences | Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full name: Umbrella Genomicsec Company S.A.S.

Profile Updated: June 17, 2024

Umbrella Genomicsec Company S.A.S. is an enterprise in Ecuador, with the main office in Guayaquil. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on March 10, 2023. 4 (2023) employees currently work for Umbrella Genomicsec Company S.A.S..

Headquarters
Av. del Bombero, 100 Bldg. , Floor 710
Guayaquil; Guayas;

Contact Details: Purchase the Umbrella Genomicsec Company S.A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Umbrella Genomicsec Company S.A.S. report to view the information.

Outstanding Shares:

Purchase the Umbrella Genomicsec Company S.A.S. report to view the information.

Registered Capital:

Purchase the Umbrella Genomicsec Company S.A.S. report to view the information.

Incorporation Date:

March 10, 2023

Key Executives

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

70%

Purchase this report to view the information.

15%

Purchase this report to view the information.

15%

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

No results were found for this company.